The methylation status of histone tails is a balance between methylation and demethylation. Results: Nitric oxide inhibits lysine demethylase 3A and alters cellular histone methylation patterns. Conclusion: Nitric oxide can significantly modify the epigenetic landscape. Significance: These results establish nitric oxide as a physiological epigenetic regulator acting through a non-classical cell signaling mechanism.
The accumulation of whole genomic sequence from thousands of individuals has made it clear that epigenetic regulation is as important as nucleotide sequence for determining final phenotypic outcomes (1, 2) . For the past 50 years, major advances in our understanding of gene expression have focused on the central dogma of molecular biology (DNA to RNA to Protein). More recently, however, the emphasis has shifted toward investigating the importance of epigenetics on phenotypic outcomes. One example is posttranslational modifications of histones which have major influences on chromatin structure and gene transcription (3) . The most studied of these modifications is acetylation, but it is now recognized that methylation, phosphorylation, ubiquitination and SUMOylation all have regulatory functions (4, 5) . Methylation of lysine residues, once thought to be an irreversible process, has gained prominence over the past decade as one of the most important histone modifications involved in genetic regulation (6) . This is due, in part, to the discovery of two families of histone demethylases that catalyze the removal of methyl groups from arginine and lysine residues. The first family is comprised of the lysine specific demethylases LSD1 and LSD2 which are FAD dependant amine oxidases (7, 8) . The other type belongs to a much larger family of Jumonji C (JMJC) domain containing demethylases. This family is comprised of 30 proteins, two thirds of which target specific Lys residues on the N-terminal tail of histone 3 (H3) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) .
The JMJC class of lysine specific demethylases (KDMs) are mononuclear Fe(II)-dependent dioxygenases that use -ketoglutarate (-KG) and oxygen (O 2 ) as cosubstrates to oxidatively demethylate specific Lys residues (11) . The common structural motif of this protein family is a 2-histidine-1-carboxylate facial triad that coordinates a non-heme Fe(II) at the catalytic center (19, 20) .
Although general catalytic mechanisms for these enzymes have been proposed, the details are an ongoing area of research and believed to be enzyme specific (9) . Methylation status of lysine (K) residues on histones can positively or negatively influence gene transcription. These lysine residues can be mono-, di-, or tri-methylated, and the functional consequences depend upon both the location and degree of this methylation. The primary targets on H3 are lysines 4, 9, 27, 36 and 79 with 4 and 9 being the most heavily modified. Methylation at K4 is generally associated with transcriptional activation while K9 methylation is typically found in silenced chromatin. H4 is also commonly methylated, especially at K20. Methylation is carried out by lysine methyltransferases (KMTs), and methylation status is therefore a dynamic process that represents a balance of KMT and KDM activities. This resulting balance can have both acute and long-term impacts on chromatin structure and mRNA expression (6, 9, (21) (22) (23) .
Nitric Oxide (•NO, nitrogen monoxide) is a biological free radical signaling molecule that regulates many physiological processes including angiogenesis, smooth muscle tone, immune response, apoptosis, and synaptic communication (24) . Like iron chelators and divalent metals (Co 2+ and Ni 2+ ), •NO has been shown to inhibit mononuclear non-heme iron oxygenases that contain the 2-His-1-carboxylate facial triad structural motif. One of the most studied examples of this interaction occurs with the HIF prolyl hydroxylase (PHD) (25) (26) (27) . Its activity is inhibited by Co 2+ and Ni 2+ by replacing the iron at the catalytic site (28) .
•NO and iron chelators have also been shown to inhibit PHD activity by either binding to or removing this catalytic iron (29) . Previously, it has been shown that the JMJC domain containing histone demethylase KDM3A is highly sensitive to inhibition by carcinogenic nickel ions (28, 30, 31) . Others have demonstrated that various dioxygenase inhibitors such as -KG analogs, hypoxia, •NO, reactive oxygen species, CoCl 2 and iron chelators like desferrioxamine (DFO) all increase histone methylation, most probably by reducing demethylase activity (32) (33) (34) (35) (36) (37) .
The common structural similarities between JMJC demethylases and other mononuclear non-heme iron oxygenases spurred us to investigate whether •NO might similarly inhibit this class of demethylases resulting in alterations in histone methylation patterns. We chose to focus on KDM3A as it is the predominant demethylase acting on the di-and monomethylated states of the heavily modified H3K9 residue (12) . We demonstrate that •NO directly inhibits KDM3A leading to the accumulation of the H3K9me2.
The contribution of methyltransferases to these increases was ruled out. Our studies are the first to provide direct mechanistic evidence for epigenetic regulation by •NO through histone modifications. This is an important finding as it is well known that the multitude of gene expression changes caused by •NO cannot be solely explained by classical •NOheme interactions or S-nitrosation of protein thiols. Further investigations into •NO-driven changes in histone methylation status at specific promoter sites will provide a model for examining many of the unexplained changes in •NO-associated gene expression.
EXPERIMENTAL PROCEDURES
Chemicals- [4,3-a] quinoxalin-1-one (ODQ) were purchased from Sigma. All cell culture reagents were purchased from Invitrogen with the exception of methionine free DMEM (AthenaES).
Cell Culture-MDA-MB-231 human breast carcinoma cells and RAW 264.7 murine macrophages were cultured in DMEM, while Jurkat T lymphocyte cells were grown in RPMI 1640. In all cases, media was supplemented with 10% fetal bovine serum and 1% penicillin/streptomycin. Additionally, media for Jurkat T cells contained 50 M 2-mercaptoethanol. Cells were grown to 80% confluence, and serum starved overnight prior to treatment. Cells were incubated in serum free, methionine free DMEM for 4 hours before addition of DETA/NO wherever necessary. For coculture experiments, RAW 264.7 cells were activated with LPS (1g/ml) for 6 hours to induce inducible nitric oxide (iNOS) expression. Subsequently, media was aspirated and Jurkat T cells were counted and added in serum free media in the presence or absence of 2mM aminoguanidine. For iron supplementation experiments, cells were treated with ferric ammonium citrate (150 g/ml) for 16 hours and washed with PBS to remove excess iron prior to treatment.
Western Blotting-Histones were extracted as described previously (37) . Whole cell lysates were collected using CellLytic TM M Cell Lysis Reagent (Sigma), supplemented with 1% protease inhibitor cocktail (Calbiochem) and 1mM PMSF (Sigma). Protein was transferred to PVDF membranes using the iBlot transfer system (Invitrogen). The membranes were blocked and incubated overnight with suitable primary antibodies: KDM3A (Abcam), H3K9me1 (Abcam), H3K9me2/me3 (Cell Signaling), G9a (Cell Signaling) or -actin (Cell Signaling 
RESULTS
Nitric Oxide inhibits KDM3A activity in vitro-KDM3A is the predominant demethylase acting upon lysine 9 of histone 3, and the monoand di-methyl modifications of this residue (H3K9me1 and H3K9me2, respectively) are its preferred substrates. Hypoxia, and inducers of "chemical hypoxia" including nickel (Ni 2+ ) cobalt (Co 2+ ), as well as dioxygenase inhibitors such as N-(methoxyoxoacetyl)-glycine methyl ester (DMOG), are recognized as strong inhibitors of JMJC demethylase activity (28, (30) (31) (32) 34, 36) . Since •NO is known to inhibit structurally similar mononuclear non-heme iron oxygenases containing the 2-His-1-carboxylate facial triad structural motif, we tested •NO's ability to inhibit KDM3A in vitro. We incubated a histone 3 peptide fragment containing a dimethylated lysine 9 (mw 2284.1, Fig. 1A ) with KDM3A and observed its near complete conversion to the unmethylated state within 60 min (mw 2256.0, (Fig. 1C) . Lesser amounts of the unmethylated peptide were detected and significant amounts of the monomethyl and di-methyl forms were still present.
Although •NO inhibited KDM3A enzymatic activity, one possibility is that •NO is simply inducing non-specific oxidative or nitrosative damage to the protein. To investigate this, we repeated the reaction in the presence of a relatively high amount of •NO, ≈20 M, given as a bolus (10 M Proli/NO). This amount of •NO was approximately the same as the total amount used in figure 1C , but the exposure time was dramatically shorter (5 sec vs. 60 min). No inhibition of KDM3A was observed (Fig. 1D ). Since the total amount of •NO was similar but the exposure time was different, we take this to indicate that the inhibitory effects of •NO on KDM3A activity are reversible, they require sustained •NO exposure, and that critical protein modifications or destruction of the enzyme most likely do not explain our results. Moreover, in parallel experiments of KDM3A treated with •NO, we could not detect any protein S-nitrosothiols by chemiluminescence, further supporting Fe(II)-•NO complex formation as the mechanism of inhibition (data not shown).
In order to determine temporal and concentration effects of •NO on enzyme activity, we measured the demethylation products of KDM3A at four different •NO concentrations over time (0 -120 min) (Fig. 1E) Although further experiments will be needed to confirm this, our data suggests a higher enzyme affinity for •NO than for O 2 . These results indicate both concentration and durationdependent effects of •NO exposure on enzyme activity.
Nitric oxide forms a histidyl-iron-nitrosyl complex in the catalytic pocket of KDM3A-In order to gain further insight into the mechanism of KDM3A inhibition by •NO, we conducted an EPR analysis of the enzyme. Figure 2 is an EPR spectrum of KDM3A in the presence of substrates, cofactors, and •NO. Spectra were not observed in the absence of •NO nor was there signal from •NO combined with all the cofactors in the absence of KDM3A. There appeared to be a superposition of spectra of more than 3-lines. The major spectrum has g-values of 2.17, 2.06, and 2.00, or possibly 2.09, 2.06, and 2.00, with the line at g = 2.17, not assigned. There are weak signals around g = 2.04 assigned to Fe(NO) 2 (-SR) 2 and a line at 1.92, not assigned. Examples of EPR signals assigned to a histidyl-iron-nitrosyl complex have g-values of 2.055, 2.033, and 2.015 for the signal from the reaction of ferritin and •NO (42) . Further, d7 and d9 forms of histidyl-iron-nitrosyl-aconitase complexes with g-values of 2.05 and 2.01 for d7 and 2.032 and 2.004 for d9 were reported (43) . gvalues of 2.07, 2.02, and 1.98 were assigned to a substrate bound iron-nitrosyl-cysteine dioxygenase site (44) . Although the anisotropy in g-values is greater than in the examples, an •NO-Fe-KDM3A complex with the 2-His-1-carboxylate facial triad is the most probable source for these spectra under our conditions. The enzymatic inhibition seen in Fig. 1 , therefore, likely results from the direct binding of •NO to the Fe(II) coordinated by the facial triad.
Physiological •NO concentrations alter histone 3 lysine 9 methylation in cultured cellsHaving established that •NO inhibits KDM3A activity in vitro, we extended these findings into a cellular system to determine if differential methylation patterns at H3K9 would similarly be observed subsequent to •NO exposure. Initially, we set out to examine changes in H3K9me2 as it is the most abundant of the 3 methylation states at H3K9 (9) and it is also the primary substrate for KDM3A.
We compared differences in methylation patterns between cells exposed to •NO and those exposed to other known inhibitors of protein activity (Ni 2+ and DFO). Similar increases in methylation at H3K9me2 were noted for all treatments (Fig. 3A) . A 24 h time course of •NO exposure demonstrated that within 8 hours increases in H3K9me2 could be observed relative to untreated controls and at 24 h the degree of methylation was still increasing (1.4 fold, Fig.  3B ). Since we observed robust and reproducible responses to •NO at 24 hours, this time point was chosen for all subsequent investigations. Next, we investigated concentration-dependent effects of •NO and determined that as little as 100 M DETA/NO resulted in detectable increases in H3K9me2, but maximal induction was achieved with 500 M DETA/NO (Fig. 3C) . Importantly, these amounts of DETA/NO generated concentrations of •NO well within the physiologic range ( Fig. 3 and as we previously reported ( (38, 39) ). Although dimethyl is the principal methyl modification at H3K9, it was also important to measure the relative changes in the mono-and tri-methyl states as change in one may be linked to changes in the others. In response to •NO, H3K9me3 was unchanged while H3K9me1 was decreased with respect to untreated controls (Fig. 3D) .
Nitric oxide increases demethylase gene expression-In addition to altering histone methylation patterns, hypoxia and inducers of chemical hypoxia have been shown to strongly induce the expression JMJC domain containing demethylases. For this reason, we compared the ability of •NO to upregulate KDM3A to that of Co 2+ , Ni 2+ , hypoxia (1% O 2 ) and the metal chelator, DFO. Figure 4A demonstrates that in cells treated with •NO, KDM3A was upregulated to the same extent as hypoxia, DFO, Co 2+ , and Ni 2+ . In response to •NO, KDM3A was upregulated in both a time and concentrationdependent manner (Fig. 4B, C) . Interestingly, these responses did not translate into decreases in H3K9me2 levels. In addition to KDM3A, we also examined the steady-state mRNA levels of 8 other demethylases that are known to be present in this cell type. Of the 9, KDM3A and KDM7A were strongly upregulated in response to 24 h •NO exposure and there was a modest upregulation of the others (Fig. 4D) . All of these enzymes can demethylate one of the three methylation states of H3K9 to some extent.
The majority of demethylation of H3K9me2, however, is believed to be carried out by KDM3A.
Methyltransferase activity does not account for increased H3K9 methylation by •NOAn increase in histone methylation can result from either a relative decrease in demethylation or a relative increase in methylation. To determine the contribution of increased H3K9 methylation by methyltransferases in response to •NO, we cultured cells in methionine free media. SAdenosyl methionine (SAM), which is synthesized from methionine and ATP, is the sole methyl donor for methyltransferase reactions. Histone methylation changes detected in cells grown in media depleted of methionine will predominately reflect alterations in demethylation as opposed to methylation (33, 34, 36, 37) . Figure  5A demonstrates that, even in methionine free media, H3K9me2 was strongly increased in response to •NO exposure compared to untreated controls.
Although active methylation did not explain changes in methylation patterns, we went on to examine methyltransferase gene expression in response to •NO.
G9a is the major methyltransferase that acts on H3K9 (45, 46) . We noted a moderate downregulation in G9a protein within 2 hours of •NO exposure and a marked decrease by 24 h (Fig. 5B) . As was seen with KDM3A, changes in G9a expression did not translate into expected changes in H3K9me2. In addition to G9a, at least 6 more methylating enzymes have been reported to act on this residue. For this reason we examined changes in steadystate mRNA levels after cellular exposure to •NO for all reported methyltransferases (Fig. 5C ). Significant increases were noted for SETDB2 and SUV39h2.
These enzymes, however, are primarily responsible for trimethylation of H3K9 (47) (48) (49) and increasing their activity would tend to decrease, rather than increase, the dimethyl state of H3K9. PRDM2 was also upregulated, however, little is known about its substrate specificity (50) .
Increasing the chelatable iron pool can abrogate the effect of •NO on histone methylationIron chelators inhibit 2-His-1-carboxylate nonheme iron oxygenases by depleting the availability of Fe(II) necessary for catalysis. These compounds react with iron in the chelatable iron pool (CIP) which is considered the major source of iron for JMJC domain dioxygenases (51) (52) (53) . We, and others, have shown previously that upon cellular exposure to •NO the CIP is quantitatively converted into paramagnetic dinitrosyliron complexes (DNIC) (39, 40, 54) . Therefore, in addition to direct enzyme inhibition by •NO, it is likely that KDM3A activity could be further impaired by the loss of iron availability via DNIC formation. To test this, we augmented the CIP, exposed cells to •NO, and measured changes in H3K9 methylation.
The CIP was increased by exposing cells to media supplemented with ferric ammonium citrate (FAC) for 16 h. The cells were then treated with two different concentrations of •NO (250 and 500 M DETA/NO). The resulting increases in CIP and DNIC formation after iron supplementation are shown in Figure 6A . The CIP was measured by changes in the g = 4.3 signal as detected by EPR (Fig. 6B ). DNIC were also quantified with EPR by measuring their characteristic signal centered at g = 2.03 (Fig. 6C,  D) . In the absence of iron supplementation, treatment with both 250 M and 500 M DETA/NO formed DNIC at concentrations roughly equal to the CIP. For both concentrations of DETA/NO, supplementation of iron greatly increased the EPR detectable signal (Fig. 6A) . Under iron supplemented conditions, the higher dose of •NO was able to convert 100% of the CIP into DNIC. At the lower •NO dose, however, only ≈50% the CIP was sequestered in the form of DNIC (Fig. 6A) . Changes in H3K9me2 were also measured under identical conditions of iron supplementation and •NO exposure. During iron supplementation, increases in H3K9me2 were only observed with the higher dose of •NO (Fig. 6E ).
•NO-mediated changes in H3K9me2 were, therefore, only observed when the CIP was completely converted into DNIC. These results support our hypothesis that sequestration of chelatable iron via DNIC formation contributes to the inhibitory effects of •NO on histone demethylases.
Cellular production of •NO changes global methylation status-Having established that histone methylation patterns were altered by physiological •NO concentrations, we sought to replicate these findings under conditions of endogenous •NO synthesis. We developed a coculture assay that allowed for measurements of global levels of H3K9me2 in Jurkat T cells grown in suspension over a monolayer of •NO-producing RAW 264.7 macrophages. Using this technique, we observed significant time-dependent increases in macrophage-derived •NO production (NO 3 -/NO 2 -) and in Jurkat T cell H3K9me2 levels (Fig.  7A) . Figure 7B demonstrates that increases in H3K9me2 correlated to increases in the total amount of •NO that the Jurkat T cells were exposed to. By changing the ratio of Jurkat T:RAW 264.7 cells, we were able to modulate the amount of •NO exposure. Addition of an iNOS inhibitor aminoguanidine, prevented NO 3 -/NO 2 -accumulation in the media and confirmed that changes in Jurkat T H3K9me2 only occurred in the presence of RAW 264.7-derived •NO (Fig.  7C) . Finally, we measured changes in KDM3A protein in Jurkat T cells following 24 h of coculture (Fig. 7D) . The total amount of KDM3A increased in response to •NO and was comparable to the change seen with 100 M DETA/NO. This effect was also abrogated by aminoguanidine. Overall, H3K9me2 and KDM3A changes in Jurkat T cells correlated strongly with •NO synthesis, and they were indistinguishable from what was observed utilizing •NO-donor compounds.
HIF-1 and sGC are not required for •NO-mediated regulation of histone modifications-
Several reports indicate that KDM3A is upregulated by hypoxia inducible factor 1 (HIF1accumulation (55) (56) (57) . Other studies have demonstrated that G9a is upregulated under hypoxia (33) . It is also well-known that •NO can strongly induce HIF-1 accumulation under normoxic conditions (58) . To investigate this pathway, we treated cells with •NO at 1% and 21% O 2 and measured KDM3A expression (Fig.  8A ).
•NO upregulated KDM3A regardless of oxygen concentration. In fact, expression was higher at 1% O₂ when •NO is predicted to destabilize HIF-1. (59) Using a HIF-1 knockdown cell line (38), we further probed the role of HIF-1 in the upregulation of KDM3A and downregulation of G9a by •NO. Figure 8B demonstrates that in the absence of HIF-1, KDM3A was still upregulated to the same extent and G9a was downregulated in response to •NO. These data strongly suggest that •NO effects these changes in a HIF-1-independent manner. When •NO-mediated changes in histone methylation patterns were examined in the HIF-1 knock-down cell line, they were indistinguishable from what was observed in the wild-type (Fig. 8C) .
The activation of soluble guanylyl cyclase (sGC) by •NO is largely considered its most important biological function (24) . To determine if changes in KDM3A and G9a protein expression were a result of sGC activation by •NO, we pretreated cells with the sGC inhibitor, ODQ. Inhibition of sGC did not affect the ability of •NO to upregulate KDM3A or downregulate G9a (Fig.  8D) 
DISCUSSION
The identification of endogenouslyproduced, epigenetic, regulatory molecules would significantly alter our understanding of gene expression in health and disease. This study provides compelling evidence that •NO falls into this category of molecules. Until now, direct inhibition of histone demethylase activity by any endogenously produced small molecule has not been reported. Our data indicate that •NO is capable of directly inhibiting the lysine specific histone demethylase KDM3A, and likely other JMJC demethylases, resulting in variations of histone methylation patterns. As these changes dramatically influence chromatin structure and gene transcription, this model provides a direct mechanism for the regulation of a multitude of genes by •NO. Classical mechanisms of •NO signaling result from its ability to regulate enzyme function by binding to the heme-center of proteins or through covalent or redox modifications of key protein residues.
Our results highlight the importance of non-heme, iron-nitrosyl complexes and provide a direct link between •NO and significant epigenetic modifications. Thus, this alternate mode of •NO signaling is unique in that it does not invoke much of the commonly relied upon complex chemistry necessary to explain phenotypic consequences of •NO synthesis.
KDM3A, like all JMJC domain mononuclear Fe(II)-dependent dioxygenases, contains the 2-His-1-carboxylate facial triad. Unlike heme proteins, this enzyme coordinates iron at only three sites, leaving three additional sites available for substrate and cofactor binding (19, 20) . Although there is no crystal structure for KDM3A, it is thought that residues H1120, D1122, and H1249 are most likely to participate in coordinating the iron. During catalysis -KG is bound in a bidentate fashion which results in the formation of a five-coordinate Fe(II) center. At this stage, the enzyme is poised to bind O₂ (19, 20) , or as we propose, •NO at the sixth coordination site (Fig. 9, inset) (60, 61) . This is agreement with our results which suggest that the affinity of this enzyme for •NO is greater than for O 2 . Although this requires further confirmatory studies, we hypothesize that, over a range of physiologic O 2 tensions, the inhibitory effect of •NO would be even more profound.
Cells treated with physiological •NO concentrations demonstrated changes in H3K9 methylation patterns in a time and concentrationdependent manner.
Collectively, we have identified three unique mechanisms that explain how •NO can mediate these changes (Fig. 9) . The JMJC class of demethylases contain a non-heme iron as a cofactor, and the chelatable iron pool is generally considered the source of this iron (51) (52) (53) .
Similarly, the iron utilized for DNIC assembly is also derived from this pool (39, 40, 54) . Just as chemical iron chelators dramatically inhibit enzyme function by starving the cell of iron (62), we observed analogous effects of DNIC formation that likely result from shifts in the enzyme equilibrium toward its iron-free apoenzyme form (Fig. 9) . Therefore, in addition to direct inhibition of demethylase activity by •NO, our data suggest that formation of DNIC indirectly inhibits enzyme activity by reducing the overall pool of available iron. This is significant as functional roles for DNIC assembly have remained obscure. With continued •NO exposure, KDM3A protein levels increased while the methyltransferase G9a protein levels decreased.
Logic would predict that increasing demethylating enzymes and decreasing methylating enzymes would favor an overall decrease in histone methylation.
What we observed, however, was significant increases in methylation at H3K9. We suspect that increased methylation subsequent to KDM3A inhibition by •NO results in compensatory changes in gene expression that attempt to override this inhibitory effect by modulating the relative concentrations of methyl modifying enzymes.
Whether JMJC demethylase inhibition by •NO is an important physiologic regulatory mechanism or associated more with •NO pathologies is also not clear. Both changes in histone methylation patterns and changes in methyl modifying enzymes occurred in response to low physiologic concentrations of •NO. , and pharmacological origins, the biological activities of •NO are independent of its source. As JMJC-demethylases are ubiquitous in nature, the manner by which •NO inhibits these enzymes in a tumor cell will be identical to how it inhibits these enzymes in a neuron, myocyte, hepatocyte, macrophage, or bacteria. Thus, like most
•NO-mediated biological responses, epigenetic effects will largely be a function of the cellular microenvironment which ultimately dictates the concentration and duration of •NO exposure (63) . Therefore, while our studies examined global methylation patterns, it is likely that subtle changes in methylation will be localized around areas of basal •NO synthesis.
It is becoming increasing clear that the regulation of methyl modifying enzymes and posttranslational histone modifications play important roles in tumor biology. For example, KDM3A expression was found to be elevated in certain types of cancer (64, 65) . In one particular study, immunohistochemical analysis revealed higher levels of KDM3A near the vessels of renal cell carcinomas, implicating a possible role in regulation of VEGF (65) . Furthermore, inhibition of KDM3A improved outcomes of the antiangiogenic VEGF antibody, bevacizumab (66) . Thus, paradoxically, a combination of VEGF inhibitors and •NO might prove beneficial despite the fact that •NO drives upregulation of angiogenesis through VEGF (67). Expression of KDM2B promotes differentiation of more aggressive forms of pancreatic cancer (68) . KDM4A promotes cellular transformation through transcriptional repression of the tumor suppressor CHD5 (69), and KDM6B has been found to promote the epithelial-mesenchymal transition (EMT) (70) .
Conversely, others have demonstrated that KDM6B acts as a tumor suppressor by regulating p53 nuclear stabilization (71) . In colorectal cancer, depletion of KDM5B induced cellular senescence (72) . In breast cancer, the methyltransferase G9a plays a critical role in the epigenetic regulation of EMT (73) . G9a has also been shown to specifically methylate p53 at K373 which correlates with inactivation of the protein (74) . Thus, downregulation of G9a by •NO may serve a tumor-suppressive function. As a whole, these studies underscore the complexity of epigenetic regulation in cancer biology and emphasize the importance of tumor type and specific epigenetic makeup. Furthermore, these novel epigenetic regulatory effects of •NO may have an important yet unrealized influence on cancer etiology.
Methyl modifying enzymes are also involved in numerous other physiological and pathological conditions. During neurogenesis, methylation of H3K27 by KDM6B plays a critical role in the maintenance of embryonic respiratory neuronal network (75) .
H3K4 demethylation by KDM5A drives differential transcriptional silencing during development (76) .
In human mesenchymal stem cells derived from bone marrow, histone demethylases KDM4B and KDM6B promote osteogenic differentiation (77) . In hematopoietic stem cells, the H3K27 demethylase KDM6A regulates stem cell migration and hematopoiesis (78) . These are just a few of numerous examples that demonstrate the critical importance and the diversity of function of methyl modifying enzymes and suggest a potential role for regulation by •NO as well. In fact, a recent study has shown dendritic outgrowth in neuronal cells arising from the decreased trimethylation at H3K9 was due to nitric oxide dependent degradation of the methyltransferase, SUV39h1 (79).
Although we have focused on lysine 9 methylation of histone 3, this is just one of a vast number of possible modifications. Understanding how histone methylation status is controlled at specific DNA sequences by •NO and how these modifications affect local protein interactions will be required to elucidate the ultimate role of •NO in epigenetic regulation. The current study revealed 3 distinct mechanisms whereby •NO could affect histone methylation patterns in general: direct inhibition of JMJC demethylases, reduction in iron cofactor availability, and regulation of KDM and KMT gene expression (Fig. 9 ). As we have discussed, both the methylation status as well as changes in steady-state levels of methyl modifying enzymes result in a multitude of phenotypic consequences. Our results revealed the dramatic effects •NO could have on both of these aspects suggesting that the magnitude of •NO-attributable responses may be much greater than previously thought. Moreover, in addition to methylation, other histone lysine modifications such as acetylation can occur on the same residue. This is a reciprocal relationship, however, and each histone modification is mutually exclusive for a specific residue (i.e. a methylated lysine cannot be acetylated and vice versa). This means that •NOmediated increases in methylation may have additional unrealized and far-reaching consequences such as precluding the formation of other critical regulatory histone marks.
Based on our current data, we classify •NO as an endogenously-produced, epigenetic, regulatory molecule. Although these epigenetic mechanisms do not eliminate or contradict currently accepted, well-defined paths of •NO signaling, they may turn out to be equally as important under a diverse set of cellular conditions.
Furthermore, these mechanisms address some fundamental problems in (1) Nitric oxide directly binds to the iron atom which is coordinated by the 2-His-1-carboxylate facial triad in the active center of KDM3A (inset). This inhibits demethylase activity by preventing the binding of O 2 . (2) Nitric oxide reacts with iron in the chelatable iron pool (CIP) and two anions (typically thiols, "R-," like glutathione or cysteine) to form dinitrosyliron complexes (DNIC). Since the CIP is the major source of iron required as a cofactor by JMJC demethylases like KDM3A, the accumulation of DNIC results in iron sequestration and indirectly contributes to enzyme inhibition.
(3) The major H3K9 methyl modifying enzymes are the methyltransferase, G9a and the demethylase, KD3MA. G9a adds a methyl group from the donor compound, S-adenosylmethionine (SAM) to yield mono-and dimethylated products. Nitric oxide upregulates KDM3A and concomitantly dowregulates G9a . Expression changes in methyl modifying enzymes will influence the overall steady-state levels of H3K9 methylation status. Figure 9 
FIGURES

Figure 1
